This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/mesh/concept/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/chebi/
n8http://bio2rdf.org/drugbank:
n17http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/pdb/
n16http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/kegg-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/pubchem-compound/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/pubchem-substance/
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03429/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03429
rdf:type
n3:Drug
n3:description
Cardiolipin (bisphosphatidyl glycerol) is an important component of the inner mitochondrial membrane, where it constitutes about 20% of the total lipid. It is typically present in metabolically active cells of the heart and skeletal muscle, in the membranes of their mitochondria, mostly in the inner membrane, and consists roughly 20% of its lipids. It has also been observed in certain bacterial membranes. It serves as an insulator and stabilizes the activity of protein complexes important to the electron transport chain. It also "glues" them together. Cardiolipin is a "double" phospholipid because it has four fatty acid tails, instead of the usual two. [Wikipedia]
n3:group
experimental
owl:sameAs
n8:DB03429 n10:DB03429
dcterms:title
Cardiolipin
adms:identifier
n12:28494 n13:DB03429 n14:449005 n15:46507093 n16:C05980 n17:CDL
n3:synonym
Diphosphatidylglycerol CDL Diphosphatidyl Glycerol
n3:synthesisReference
Moghis Ahmad, Murali Ukkalam, Imran Ahmad, "Cardiolipin molecules and methods of synthesis." U.S. Patent US20050266068, issued December 01, 2005.
n5:hasConcept
n6:M0003459
n3:IUPAC-Name
n4:271B4766-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B476C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B476B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4768-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4769-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B476A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4764-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4762-363D-11E5-9242-09173F13E4C5 n4:271B4765-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4763-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4772-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4773-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B476D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B476E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4770-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B476F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4771-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4778-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B477A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B477B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4777-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4776-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4779-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4767-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4774-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4775-363D-11E5-9242-09173F13E4C5